Literature DB >> 3086036

Genetic control of the susceptibility to pneumococcal infection.

D E Briles, J Horowitz, L S McDaniel, W H Benjamin, J L Claflin, C L Booker, G Scott, C Forman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3086036     DOI： 10.1007/978-3-642-70986-9_7

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  19 in total

1.  Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres.

Authors:  K Allaoui-Attarki; S Pecquet; E Fattal; S Trollé; E Chachaty; P Couvreur; A Andremont
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

2.  Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae.

Authors:  D E Briles; M J Crain; B M Gray; C Forman; J Yother
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.

Authors:  T Kelly; J P Dillard; J Yother
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

4.  Essential role for cellular phosphoglucomutase in virulence of type 3 Streptococcus pneumoniae.

Authors:  G G Hardy; A D Magee; C L Ventura; M J Caimano; J Yother
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface.

Authors:  Bing Ren; Alexander J Szalai; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.

Authors:  D E Briles; C Forman; J C Horowitz; J E Volanakis; W H Benjamin; L S McDaniel; J Eldridge; J Brooks
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

7.  Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

Authors:  S Langermann; S R Palaszynski; J E Burlein; S Koenig; M S Hanson; D E Briles; C K Stover
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

Review 8.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniae.

Authors:  Hazeline Roche; Bing Ren; Larry S McDaniel; Anders Håkansson; David E Briles
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type.

Authors:  L S McDaniel; J S Sheffield; P Delucchi; D E Briles
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.